abbott laboratories (ABT:New York)
abbott laboratories (ABT) Snapshot
|
Open
$37.17
|
Previous Close
$37.48
|
|
|
Day High
$37.84
|
Day Low
$37.11
|
|
|
52 Week High
05/22/13 - $38.77
|
52 Week Low
06/5/12 - $28.45
|
|
|
Market Cap
58.9B
|
Average Volume 10 Days
7.2M
|
|
|
EPS TTM
$4.25
|
Shares Outstanding
1.6B
|
|
|
EX-Date
04/11/13
|
P/E TM
8.9x
|
|
|
Dividend
$0.56
|
Dividend Yield
3.44%
|
abbott laboratories (ABT) Latest News
abbott laboratories (ABT) Related Businessweek News
abbott laboratories (ABT) Details
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
abbott laboratories (ABT) Top Compensated Officers
abbott laboratories (ABT) Key Developments
Abbott Laboratories announced CE Mark in Europe for the XIENCE Xpedition(TM) 48 Everolimus Eluting Coronary Stent System, the treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD). XIENCE Xpedition 48 leverages the proven design and clinical outcomes of the XIENCE family of drug eluting stents in a unique 48 mm length. The company continues to offer physicians more options for the treatment of patients with complex coronary artery disease and is the only major manufacturer to offer a coronary drug eluting stent greater than 38 mm in length. XIENCE Xpedition 48 is the latest in a long history of stent innovations pioneered by Abbott, which was to offer physicians size-specific metallic stents for use in small and large vessels of the heart.
Abbott Laboratories announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes. The HbA1c test is a blood test that reflects a person's average blood glucose levels over the past three months. In 2009, an international expert committee recommended that physicians may use an HbA1c test for the diagnosis of type 2 diabetes and identification of patients at risk for developing diabetes if the assay meets specific performance criteria, such as certification and standardization processes outlined by the National Glycohemoglobin Standardization Program (NGSP) and the International Federation of Clinical Chemistry (IFCC). Diabetes can be managed by using diabetes medicines, making important lifestyle changes related to diet and exercise, and monitoring blood glucose and HbA1c levels.(2) For people whose HbA1c test results are normal, doctors may recommend that testing be repeated at least every three years or more frequently depending on a person's initial results and risk status.
Abbott Laboratories Presents at UBS Global Healthcare Conference, May-22-2013 08:30 AM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Brian J. Blaser, Executive Vice President of Diagnostic Products, Thomas C. Freyman, Chief Financial Officer and Executive Vice President of Finance.
| Recently Viewed | |||
| ABT:US | $37.76 USD | +0.28 | |
| Company | Last | Change |
| AstraZeneca PLC | 3,428 GBp | +1.50 |
| Bayer AG | €84.46 EUR | +0.62 |
| Eli Lilly & Co | $54.14 USD | -0.60 |
| Koninklijke Philips NV | €22.53 EUR | +0.085 |
| Medtronic Inc | $51.33 USD | -0.13 |
| View Industry Companies | ||
Industry Analysis
ABT
Industry Average
| Valuation | ABT | Industry Range |
| Price/Earnings | 9.8x |
|
| Price/Sales | 1.5x |
|
| Price/Book | 2.6x |
|
| Price/Cash Flow | 11.1x |
|
| TEV/Sales | 1.1x |
|
Post a JobJobs
- Santa Clara, CA | Abbott LaboratoriesPosted: May 14
- Carlsbad, CA | Abbott LaboratoriesPosted: May 20
- Santa Ana, CA | Abbott LaboratoriesPosted: May 23
- Los Angeles, CA | Abbott LaboratoriesPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact ABBOTT LABORATORIES, please visit www.abbott.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








